A prostate specific antigen (PSA) bounce greater than 1.4 ng/mL is clinically significant after external beam radiotherapy for prostate cancer

Steven J. Feigenberg, Alexandra L. Hanlon, Eric M. Horwitz, Robert G. Uzzo, Debra Eisenberg, Alan Pollack

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint Dive into the research topics of 'A prostate specific antigen (PSA) bounce greater than 1.4 ng/mL is clinically significant after external beam radiotherapy for prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences